Tracheostomy in motor neurone disease.

Humans Motor Neuron Disease / complications Respiratory Insufficiency / etiology Tracheostomy / methods
amyotrophic lateral sclerosis motor neurone disease prognosis therapy tracheostomy ventilation

Journal

Practical neurology
ISSN: 1474-7766
Titre abrégé: Pract Neurol
Pays: England
ID NLM: 101130961

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 18 02 2019
revised: 03 04 2019
accepted: 08 04 2019
pubmed: 6 7 2019
medline: 28 4 2020
entrez: 6 7 2019
Statut: ppublish

Résumé

Tracheostomy-associated ventilation for the respiratory insufficiency caused by amyotrophic lateral sclerosis (motor neurone disease (MND)) is a complex issue with practical, ethical and economic dimensions. This article considers the current prevalence of tracheostomy in MND, the evidence for its benefit both for survival and quality of life, and the practicalities of its implementation. The decision to request invasive ventilatory support is among the most challenging for those living with MND. Neurologists should be prepared to discuss this option openly and objectively: we suggest a framework for discussion, including withdrawal of therapy.

Identifiants

DOI: 10.1136/practneurol-2018-002109 PMID: 31273080
pubmed: 31273080
pii: practneurol-2018-002109
doi: 10.1136/practneurol-2018-002109
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

467-475

Subventions

Organisme : Motor Neurone Disease Association
ID : TURNER/OCT18/989-797
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Martin R Turner (MR)

Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK martin.turner@ndcn.ox.ac.uk.
ORCID: 0000-0003-0267-3180

Christina Faull (C)

LOROS Hospice and University Hospitals of Leicester, Leicester, UK.

Christopher J McDermott (CJ)

Sheffield Institute of Translational Neuroscience, University of Sheffield, Sheffield, UK.
ORCID: 0000-0002-1269-9053

Annabel H Nickol (AH)

Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.

Jonathan Palmer (J)

Thoracic Medicine, University Hospitals Plymouth NHS Trust, Plymouth, UK.

Kevin Talbot (K)

Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Tracheostomy in motor neurone disease.
questionsmedicales.fr › Maladies du système nerveux › Maladies neuromusculaires › Maladies du motoneurone › Tracheostomy in motor neurone disease.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Troubles respiratoires › Insuffisance respiratoire › Tracheostomy in motor neurone disease.
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de chirurgie thoracique › Trachéostomie › Tracheostomy in motor neurone disease.